Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shanghai ChemExplorer is a prominent contract research organization (CRO) based in Shanghai, China, that specializes in medicinal chemistry and drug discovery services. Established in 2002 as a strategic collaboration between WuXi AppTec and Eli Lilly, the company was designed to provide dedicated research and development support for global pharmaceutical pipelines. It offers a wide range of services including synthetic chemistry, lead optimization, and chemical library synthesis. As a subsidiary of WuXi AppTec, Shanghai ChemExplorer utilizes state-of-the-art laboratory facilities to assist clients in accelerating the transition from hit identification to clinical candidates. The company has played a pivotal role in the growth of the outsourcing model within the life sciences industry in Asia.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shanghai ChemExplorer.